(Total Views: 497)
Posted On: 08/08/2019 6:20:32 PM
Post# of 150891
Here is the announcement of the meeting from the July 30th 8-K filing.
Item 5.08 Shareholder Director Nominations.
On July 30, 2019, the board of directors of CytoDyn Inc., a Delaware corporation (the “Company”), determined that the Company’s 2019 annual meeting of stockholders will be held on September 12, 2019 and established August 5, 2019 as the record date for determining stockholders entitled to notice of, and to vote at, the meeting. The Company will publish additional details regarding time, venue and matters to be voted on at the meeting in its proxy materials to be distributed to stockholders.
In accordance with the Company’s bylaws and the rules and regulations of the Securities and Exchange Commission, stockholders will have until 5:00 P.M. (Pacific Time) on August 12, 2019 to submit stockholder proposals and request proxy access with respect to any business to be considered at the annual meeting. Any such proposals should be directed to the following address:
CytoDyn Inc.
1111 Main Street, Suite 660 Vancouver, Washington 98660 Attn: Secretary
https://www.cytodyn.com/investors/sec-filings...211526.pdf
Item 5.08 Shareholder Director Nominations.
On July 30, 2019, the board of directors of CytoDyn Inc., a Delaware corporation (the “Company”), determined that the Company’s 2019 annual meeting of stockholders will be held on September 12, 2019 and established August 5, 2019 as the record date for determining stockholders entitled to notice of, and to vote at, the meeting. The Company will publish additional details regarding time, venue and matters to be voted on at the meeting in its proxy materials to be distributed to stockholders.
In accordance with the Company’s bylaws and the rules and regulations of the Securities and Exchange Commission, stockholders will have until 5:00 P.M. (Pacific Time) on August 12, 2019 to submit stockholder proposals and request proxy access with respect to any business to be considered at the annual meeting. Any such proposals should be directed to the following address:
CytoDyn Inc.
1111 Main Street, Suite 660 Vancouver, Washington 98660 Attn: Secretary
https://www.cytodyn.com/investors/sec-filings...211526.pdf
(1)
(0)
Please do your own due diligence. All my posts and comments are not to be considered investment advice.
Scroll down for more posts ▼
